A Phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease

✍ Scribed by James R. Berenson; Robert Vescio; Kathryn Henick; Carol Nishikubo; Matthew Rettig; Regina A. Swift; Francisco Conde; Joseph M. Von Teichert

• Publisher: John Wiley and Sons
• Year: 2001
• Tongue: English
• Weight: 127 KB
• Volume: 91
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/1097-0142(20010101)91:1<144::aid-cncr19>3.0.co;2-q